Luye Pharma Group Ltd. (OTCMKTS:LYPHF – Get Free Report) saw a large decline in short interest in July. As of July 31st, there was short interest totaling 593,731 shares, a decline of 57.3% from the July 15th total of 1,389,331 shares. Based on an average daily volume of 417 shares, the days-to-cover ratio is presently 1,423.8 days.
Luye Pharma Group Stock Performance
OTCMKTS LYPHF remained flat at $0.27 on Friday. The firm’s fifty day simple moving average is $0.25 and its two-hundred day simple moving average is $0.32. Luye Pharma Group has a one year low of $0.20 and a one year high of $0.33.
Luye Pharma Group Company Profile
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
Featured Stories
- Five stocks we like better than Luye Pharma Group
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
- Microsoft’s Maia 300 Chip Targets NVIDIA’s AI Dominance
- 3 Unexpected ETFs Crushing the Market This Summer
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
